Biofrontera(BFRI.US)

Last Updated 19:00:00 ET
longbridge loading
Company Encyclopedia
View More
name
Biofrontera
BFRI.US
Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. It offers Ameluz, BF-RhodoLED, RhodoLED XL lamp series, and RhodoLED Lamps, which are used for the treatment of actinic keratosis, which are pre-cancerous skin lesions. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.
4.623 T
BFRI.USMarket value -Rank by Market Cap -/-

Financial Score

19/05/2026 Update
C
PharmaceuticalsIndustry
Industry Ranking100/190
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreD
    • ROE-339.04%E
    • Profit Margin-25.66%E
    • Gross Margin79.02%A
  • Growth ScoreB
    • Revenue YoY13.70%B
    • Net Profit YoY3.82%C
    • Total Assets YoY49.43%A
    • Net Assets YoY1194.24%A
  • Cash ScoreB
    • Cash Flow Margin84.02%C
    • OCF YoY13.70%B
  • Operating ScoreA
    • Turnover2.09A
  • Debt ScoreE
    • Gearing Ratio75.51%E

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    This Hanover Insurance Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Tuesday

    benzinga_article·
    US
    BTMWW
    -17.39%
    US
    BFRI
    +1.45%
    US
    GBTC
    -0.10%
    benzinga_article·
    US
    BTMWW
    -17.39%
    US
    BFRI
    +1.45%
    US
    GBTC
    -0.10%

    Biofrontera Reports Q1 2026: Revenue $10.1M, Gross Margin ~80%, Adjusted EBITDA $(3.6) M

    TradingView·
    US
    BFRI
    +1.45%
    US
    XLV
    +1.10%
    US
    IHE
    +1.26%
    TradingView·
    US
    BFRI
    +1.45%
    US
    XLV
    +1.10%
    US
    IHE
    +1.26%

    Biofrontera | 8-K: FY2026 Q1 Revenue Misses Estimate at USD 10.08 M

    Earnings Watch·
    US
    BFRI
    +1.45%
    Earnings Watch·
    US
    BFRI
    +1.45%

    Biofrontera Inc. Reports First Quarter 2026 Financial Results and Provides a Business Update

    Unusual Whales·
    US
    BFRI
    +1.45%
    US
    FBT
    +0.54%
    US
    ARKG
    +0.04%
    Unusual Whales·
    US
    BFRI
    +1.45%
    US
    FBT
    +0.54%
    US
    ARKG
    +0.04%

    Biofrontera Inc. to Report First Quarter 2026 Financial Results and Host a Conference Call on May 14, 2026 | BFRI Stock News

    StockTitan·
    US
    BFRI
    +1.45%
    US
    VHT
    +0.97%
    US
    SBIO
    -1.24%
    StockTitan·
    US
    BFRI
    +1.45%
    US
    VHT
    +0.97%
    US
    SBIO
    -1.24%
    © 2026 Longbridge｜Disclaimer